Clinical Trial Update: Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing cefiderocol plus ampicillin-sulbactam vs. colistin with or without meropenem for carbapenem-resistant Acinetobacter baumannii i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Bacteremia
• Acinetobacter Baumannii Infection
• Acinetobacter Pneumonia

Drugs mentioned

• Colistin (colistin)
• Fetroja (cefiderocol)
• Merrem (meropenem)
• UNASYN (Ampicillin sodium and sulbactam sodium)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia | Phase 4 | Status: RECRUITING